MENLO PARK, Calif.–(BUSINESS WIRE)–Kedalion Therapeutics, Inc., a clinical-stage company focused on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream™ platform, today announced a shift in its management team as current CEO, Peter Noymer, Ph.D., transitions from the company to pursue new opportunities. Mark Blumenkranz, M.D., M.M.S., co-Founder will continue in … [Read more…]

Company supports organization’s efforts to accelerate life-changing breakthroughs in curing type 1 diabetes ATLANTA–(BUSINESS WIRE)–#diabetes–Juvenile Diabetes Research Foundation (JDRF) today announced The Aliera Companies, a holding and management company providing compliance, accounting, human resources and training services to its subsidiaries, is a Silver Partner for the 2019 One Walk Atlanta. The family-friendly 5K walk is … [Read more…]

Construction Underway for Best-In-Class Assisted Living and Memory Care Community CHICAGO–(BUSINESS WIRE)–Senior Lifestyle Corporation, an industry-leading owner, operator and developer of senior living communities, and Kaufman Jacobs, a Chicago-based privately-held real estate investment firm, broke ground on The Sheridan at River Forest on September 30, 2019. The Sheridan at River Forest will feature 92 assisted … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–#mediledger—Cumberland announced today that it has joined forces with Chronicled as a preferred systems integration partner for the San Francisco-based technology company’s MediLedger Project, an initiative that builds blockchain-powered ecosystems and supply chain solutions. Chronicled is helping the pharmaceutical industry to launch a permissioned blockchain network based on open standards and specifications. Cumberland … [Read more…]

Meeting Highlights Include New Product Introductions, an OCT Technology Symposium and the Debut of Topcon Healthcare the “Next Generation in Healthcare Insights Through the Eye” OAKLAND, N.J.–(BUSINESS WIRE)–#AAO—Topcon Medical Systems, a leading provider of medical devices and software solutions for the eye care community, is pleased to announce its participation in the 2019 American Academy … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cardiac Pacemakers – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Cardiac Pacemakers market worldwide is projected to grow by US$2.4 Billion, driven by a compounded growth of 6.7%. External Pacemaker Devices, one of the segments analyzed and sized in this study, displays the potential to grow at over … [Read more…]

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#Clinicaltrials–Please note the Hope Biosciences boilerplate has been updated. The corrected release reads: VIRTRIAL AWARDED FDA-APPROVED DECENTRALIZED CLINICAL TRIAL WITH HOPE BIOSCIENCES VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSCs) for the treatment of spinal … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Country Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Opportunities for Suppliers” report has been added to ResearchAndMarkets.com’s offering. About this Report This new 366-page report from the author presents detailed analysis of the Respiratory Disease market in the US, Europe … [Read more…]

Three recent clinical publications demonstrate that Cellvizio® AQ-Flex™ 19 Confocal Miniprobe significantly improves diagnostic accuracy versus standard of care, positively impacting management of patients with pancreatic cystic lesions PARIS & BOSTON–(BUSINESS WIRE)–Regulatory News: Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA,) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced … [Read more…]

The trial, which received a $4.1 million in grants from the National Institutes of Health and Gateway for Cancer Research, combines City of Hope’s unique CAR T cell therapy with immune checkpoint inhibitors DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope–City of Hope has opened a first-in-human clinical trial for patients with recurrent glioblastoma – the trial is the first … [Read more…]